Comparison of two approaches to basal-bolus insulin therapy in patients with type 2 diabetes and inadequate glycemic control on oral therapy: comparison of premixed insulin lispro mid mixture with separate basal and bolus insulin injections.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Insulin lispro (Primary) ; Insulin glargine; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOOX
- Sponsors Eli Lilly and Company
- 17 Dec 2009 Patient numbers amended from 469 to 484 as reported by ClinicalTrials.gov.
- 21 Oct 2009 Results presented at the 20th World Diabetes Congress.
- 02 Oct 2009 Results were reported at the 45th Annual Meeting of the European Association for the Study of Diabetes.